Detalles de la búsqueda
1.
Real-world data on patients with early breast cancer who were prescribed abemaciclib adjuvant therapy in Japan.
Future Oncol
; : 1-10, 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38861285
2.
[Efficacy and Safety Analysis of Selpercatinib in Patients with RET Fusion-Positive Non-Small Cell Lung Cancer-Results from the Japanese Subset of a Global Phase 1/2 Study].
Gan To Kagaku Ryoho
; 49(6): 669-675, 2022 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-35799394
3.
Safety and effectiveness of ramucirumab and docetaxel: a single-arm, prospective, multicenter, non-interventional, observational, post-marketing safety study of NSCLC in Japan.
Expert Opin Drug Saf
; 21(5): 691-698, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34941463
4.
[Role of pharmaceutical company pharmacist in provision of drug information for cancer chemotherapy].
Gan To Kagaku Ryoho
; 36(4): 687-91, 2009 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-19381050
5.
[What happened during these 12 years since CPT-11 was launched in Japan ?].
Gan To Kagaku Ryoho
; 33(11): 1685-90, 2006 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-17108743
6.
Applicability of Selective Data Collection to Cancer Clinical Studies for Supplemental Marketing Approvals: Frequency of Adverse Reactions Observed During Supplemental Approval Compared With First Approval.
Ther Innov Regul Sci
; 50(4): 472-479, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30227018
Resultados
1 -
6
de 6
1
Próxima >
>>